Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Johnson PharmacareBOM:532154 25 Market Cap is ₹264.00 Mil as of Jul. 14, 2026. GuruFocus rates BOM:532154 with a GF Score™ of 25/100. The stock has 4 warning signs investors should review. Among 638 Diversified Financial Services companies, Johnson Pharmacare ranks worse than 77.74% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Johnson Pharmacare's share price for the quarter that ended in Mar. 2026 was ₹0.48. Johnson Pharmacare's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 550.00 Mil. Therefore, Johnson Pharmacare's market cap for the quarter that ended in Mar. 2026 was ₹264.00 Mil.
Johnson Pharmacare's quarterly market cap
declined
from Sep. 2025 (₹418.00 Mil) to Dec. 2025 (₹319.00 Mil) and
declined
from Dec. 2025 (₹319.00 Mil) to Mar. 2026 (₹264.00 Mil).
Johnson Pharmacare's annual market cap
increased
from Mar. 2024 (₹379.50 Mil) to Mar. 2025 (₹511.50 Mil) but then
declined
from Mar. 2025 (₹511.50 Mil) to Mar. 2026 (₹264.00 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Johnson Pharmacare's Enterprise Value for Today is ₹477.22 Mil.
Johnson Pharmacare (BOM:532154) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Johnson Pharmacare Market Cap Related Terms
Johnson Pharmacare Market Cap Historical Data
* Premium members only.
The historical data trend for Johnson Pharmacare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532154 vs XXI, CCXI, DMII: Market Cap Comparison
For the Shell Companies subindustry, Johnson Pharmacare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Johnson Pharmacare Market Cap vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Johnson Pharmacare's Market Cap distribution charts can be found below:
* The bar in red indicates where Johnson Pharmacare's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Johnson Pharmacare's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Johnson Pharmacare (BOM:532154) has a Market Cap of ₹264.00 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Johnson Pharmacare and its competitors. According to the industry distribution chart, Johnson Pharmacare ranks #496 out of 638 companies in the Diversified Financial Services industry, placing it in the top 77.7%.
Is Johnson Pharmacare's Market Cap too high?
Johnson Pharmacare's current Market Cap is ₹264.00 Mil. Based on the distribution chart, Johnson Pharmacare ranks #496 out of 638 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Johnson Pharmacare has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Johnson Pharmacare's Market Cap compare to XXI and CCXI?
According to the Diversified Financial Services industry distribution chart, Johnson Pharmacare ranks #496 out of 638 companies for Market Cap. This places Johnson Pharmacare in the lower half of its industry. The industry median Market Cap is 92.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Diversified Financial Services company?
The median Market Cap among Diversified Financial Services companies is 92.25, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Johnson Pharmacare and its competitors. For the Diversified Financial Services industry, the median Market Cap is 92.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Johnson Pharmacare's current Market Cap is ₹264.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Johnson Pharmacare stock overvalued right now?
Johnson Pharmacare (BOM:532154) has a current Market Cap of ₹264.00 Mil. The current Market Cap is ₹264.00 Mil. Johnson Pharmacare's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Johnson Pharmacare (BOM:532154), the current Market Cap is ₹264.00 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532154 has been successfully added to your 
